Aura Biosciences, Inc. AURA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-29
Aura Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,005,362 | $22.7M | 4.73% |
| MILLENNIUM MANAGEMENT LLC | 1,097,627 | $7.3M | 1.73% |
| RENAISSANCE TECHNOLOGIES LLC | 102,100 | $683,049 | 0.16% |
| AQR CAPITAL MANAGEMENT LLC | 46,143 | $308,697 | 0.07% |
| Point72 Asset Management, L.P. | 21,708 | $145,227 | 0.03% |
| CITADEL ADVISORS LLC | 12,503 | $83,645 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.